SynCore Biotechnology Co.,Ltd announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 2.330 million compared to TWD 1.947 million a year ago. Operating loss was TWD 123.835 million compared to TWD 70.513 million a year ago. Net loss was TWD 122.053 million compared to TWD 69.150 million a year ago. Basic loss per share was TWD 1.46 compared to TWD 0.99 a year ago. For the half year, sales was TWD 8.802 million compared to TWD 3.771 million a year ago. Operating loss was TWD 188.035 million compared to TWD 122.203 million a year ago. Net loss was TWD 185.582 million compared to TWD 121.058 million a year ago. Basic loss per share was TWD 2.23 compared to TWD 1.73 a year ago.